Acute myocardial infarction and combined oral contraceptives: Results of an international multicentre case-control study

Lancet

Volumn 349, Issue 9060, 1997, Pages 1202-1209

  Poulter, N R ^a   Meirik, O ^a   Chang, C L ^a   Farley, T M M ^a   Kelaghan, J ^a   Marmot, M G ^a   Debert Ribeiro, M ^a   Medina, E ^a   Artigas, J ^a   He, S ^a   Hui, Z Y ^a   De Wei, Z ^a   Weijin, Z ^a   Rojas, O ^a   Heinemann, L ^a   Donnan, S ^a   Ho, S ^a   Bartfai, G ^a   Kisjanto, J ^a   Wilks, R ^a   Agwamda, R ^a   Ruiz, R ^a   Kozuh Novak, M ^a   Dusitsin, N ^a   Virutamasen, P ^a   Phanthumchinda, K ^a   Koetsawang, S ^a   Piya Anant, M ^a   Vessey, M ^a   Demirovic, J ^a   Belkic, K ^a   Mwandila, W S ^a   Mutale, C M ^a   Matenga, J ^a   Wilson, A ^a   Petitti, D ^a   Perlman, J ^a   Holck, S ^a   Lawley, S ^a   Smith, S ^a   Shipley, M ^a   more..

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ORAL CONTRACEPTIVE AGENT;

ACUTE HEART INFARCTION; ADULT; AGE; ANAMNESIS; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTENSION; INTERVIEW; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; QUESTIONNAIRE;

EID: 19244367470     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)02358-1     Document Type: Article

References (37)

1. Boyce J, Fawcett JW, Noall EWP Coronary thrombosis and Conovid. Lancet. i:1963;111.
2. Inman WHW, Vessey MP Investigation of deaths from pulmonary, coronary and cerebral thrombosis and embolism in women of child-bearing age. BMJ. ii:1968;193-199.
3. Vessey MP, Doll R Investigation of relation between use of oral contraceptives and thromboembolic disease. BMJ. ii:1969;651-657.
4. Mann JI, Thorogood M, Water WE, Powell C Oral contraceptives and myocardial infarction in young women. BMJ. ii:1975;631-632.
5. Mann JI, Inman WHW Oral contraceptives and death from myocardial infarction. BMJ. ii:1975;245-248.
6. Jick H, Dinan B, Rothman K Oral contraceptives and non-fatal myocardial infarction. JAMA. 239:1978;1403-1406.
7. Shapiro S, Slone D, Rosenberg L, Kaufman DW, Stoley PD, Miettinen OS Oral contraceptive use in relation to myocardial infarction. Lancet. i:1979;743-747.
8. Rosenberg L, Hennekens CH, Rosner B, Belanger C, Rothman KJ, Speizer FE Oral contraceptive use in relation to non-fatal myocardial infarction. Am J Epidemiol. 111:1980;59-66.
9. Krueger DE, Ellenberg SS, Bloom Set al. Fatal myocardial infarction and the role of oral contraceptives. Am J Epidemiol. 125:1980;832-843.
10. Slone D, Shapiro S, Kaufman DW, Rosenberg L, Miiettinen OS, Stolley PD Risk of myocardial infarction in relation to current and discontinued use of oral contraceptives. N Engl J Med. 305:1981;420-424.
11. Adam SA, Thorogood M, Mann JI Oral contraception and myocardial infarction revisited: the effects of new preparations and prescribing patterns. Br J Obstet Gynaecol. 88:1981;838-845.
12. La Vecchia C, Franceschi S, Decarli A, Pampalona S, Tognoni G Risk factors for myocardial infarction in young women. Am J Epidemiol. 125:1987;832-843.
13. Talbott E, Kuller LH, Detre Ket al. Reproductive history of women dying of sudden cardiac death: a case-control study. Int J Epidemiol. 18:1989;589-594.
14. Ananjevic-Pandey J, Vlajinac H Myocardial infarction in young women with reference to oral contraceptive use. Int J Epidemiol. 18:1989;585-588.
15. Thorogood M, Mann JI, Murphy M, Vessey M Is oral contraceptive use still associated with an increased risk of fatal myocardial infarction? Report of a case-control study. Br J Obstet Gynaecol. 98:1991;1245-1253.
16. Rosenberg L, Palmer JR, Lesko SM, Shapiro S Oral contraceptive use and the risk of myocardial infarction. Am J Epidemiol. 131:1990;1009-1016.
17. Sidney S, Petitti DB, Quesenberry CP, Klatsky AL, Ziel HK, Wolf S Myocardial infarction in users of low dose oral contraceptives. Obstet Gynaecol. 88:1996;939-944.
18. Stampfer MJ, Willett WC, Colditz GA, Speizer FE, Hennekens CH A prospective study of oral contraceptive agents and risk of cardiovascular diseases. N Engl J Med. 319:1988;1313-1317.
19. Croft P, Hannaford P Risk factors for acute myocardial infarction in women. BMJ. 298:1989;165-168.
20. Mant D, Villard-Mackintosh L, Vessey MP, Yeates D Myocardial infarction and angina pectoris in young women. J Epidemiol Commun Health. 41:1987;215-219.
21. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. A multinational case-control study of cardiovascular disease and steroid hormone contraceptives: description and validation of methods. J Clin Epidemiol 1995; 48: 1513-47.
22. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. Lancet 1995; 346: 1575-82.
23. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. Lancet 1995; 346: 1582-88.
24. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Ischaemic stroke and combined oral contraceptives: results of an international, multicentre, case-control study. Lancet 1996; 348: 498-505.
25. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Haemorrhagic stroke, overall stroke risk, and combined oral contraceptives: results of an international, multicentre, case-control study. Lancet 1996; 348: 505-10.
26. WHO MONICA Project. MONICA manual. Geneva: WHO, 1990; part IV(a): 11-32.
27. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Reliability of data from proxy respondents in a case-control study of cardiovascular disease and oral contraceptive use. J Epidemiol Commun Health 1996; 50: 674-80.
28. Lewis MA, Spitzer WO, Heinemann LAJet al. Third generation oral contraceptives and risk of myocardial infarction: an international case-control study. BMJ. 312:1996;88-90.
29. Maldonado G, Greenland S Simulation study of confounder-selection strategies. Am J Epidemiol. 138:1993;923-936.
30. Breslow NE, Day NE. Statistical methods in cancer research I: analysis of case-control studies. Lyon: International Agency for Research on Cancer, 1980: 192-246.
31. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A Myocardial infarction and coronary deaths in the WHO MONICA Project: registration procedures, event rates and case-fatality rates in 38 populations from 21 countries in four continents. Circulation. 90:1994;583-612.
32. Stadel BV Medical progress: oral contraceptives and cardiovascular disease. N Engl J Med. 305:1981;672-677.
33. Meade TW, Greenberg G, Thompson SG Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-μg oestrogen preparations. BMJ. 280:1980;1157-1161.
34. Rosenberg L, Kaufman DW, Helmrich SP, Miller DR, Stolley PD, Shapiro S Myocardial infarction and cigarette smoking in women younger than 50 years of age. JAMA. 253:1985;2965-2969.
35. Jain AK Cigarette smoking, use of oral contraceptives and myocardial infarction. Am J Obstet Gynecol. 126:1976;301-307.
36. Realini JP, Goldzieher JW Oral contraceptives and cardiovascular disease: a critique of the epidemiologic studies. Am J Obstet Gynecol. 152:1985;729-798.
37. Vessey MP. The Jephcott Lecture 1989. An overview of the benefits and risks of combined oral contraceptives. In: Mann RD, ed. Oral contraceptives and breast cancer. Lancaster: Parthenon Publishing, 1990: 121-32.